A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma

被引：0
|
作者：
Satoshi Murahashi
Daisuke Takahari
Takeru Wakatsuki
Naoki Fukuda
Takashi Ichimura
Mariko Ogura
Masato Ozaka
Eiji Shinozaki
Izuma Nakayama
Tomohiro Matsushima
Hiroki Osumi
Keisho Chin
Kensei Yamaguchi
机构：
[1] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Ramucirumab; Monotherapy; Gastric Cancer; Japanese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：92 / 97
页数：5
相关论文
共 50 条
  • [41] Safety and Pharmacokinetics of Second-line Ramucirumab plus FOLFIRI in Japanese Patients with Metastatic Colorectal Carcinoma
    Yoshino, Takayuki
    Yamazaki, Kentaro
    Gotoh, Masahiro
    Nasroulah, Federico
    Gao, Ling
    Yoshizuka, Naoto
    Ohtsu, Atsushi
    ANTICANCER RESEARCH, 2015, 35 (07) : 4003 - 4007
  • [42] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Ishikawa, Masashi
    Iwasa, Satoru
    Nagashima, Kengo
    Aoki, Masahiko
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Saruta, Masayuki
    Boku, Narikazu
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 533 - 540
  • [43] Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis
    Masashi Ishikawa
    Satoru Iwasa
    Kengo Nagashima
    Masahiko Aoki
    Hiroshi Imazeki
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Masayuki Saruta
    Narikazu Boku
    Investigational New Drugs, 2020, 38 : 533 - 540
  • [44] Oral etoposide for patients with metastatic gastric adenocarcinoma
    Ajani, JA
    Mansfield, PF
    Dumas, P
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (02): : 112 - 114
  • [45] Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data
    Muro, Kei
    Jen, Min-Hua
    Cheng, Rebecca
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2261 - 2267
  • [46] Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer
    Chung, Hyun Cheol
    Kok, Victor C.
    Cheng, Rebecca
    Hsu, Yanzhi
    Orlando, Mauro
    Fuchs, Charles
    Cho, Jae Yong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (03) : 204 - 209
  • [47] Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma
    Alici, Suleyman
    Kaya, Serap
    Izmirli, Mustafa
    Tuncer, Ilyas
    Dogan, Ekrem
    Ozbek, Hanefi
    Sayariloglu, Hayriye
    MEDICAL SCIENCE MONITOR, 2006, 12 (05): : CR221 - CR229
  • [48] The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma
    Garrido, Marcelo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (10) : 1005 - 1010
  • [49] Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study
    Parisi, Alessandro
    Cortellini, Alessio
    Roberto, Michela
    Venditti, Olga
    Santini, Daniele
    Dell'Aquila, Emanuela
    Stellato, Marco
    Marchetti, Paolo
    Occhipinti, Mario Alberto
    Zoratto, Federica
    Mazzuca, Federica
    Tinari, Nicola
    De Tursi, Michele
    Iezzi, Laura
    Natoli, Clara
    Ratti, Margherita
    Pizzo, Claudio
    Ghidini, Michele
    Porzio, Giampiero
    Ficorella, Corrado
    Cannita, Katia
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (09) : 2365 - 2373
  • [50] Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial
    Kudo, Masatoshi
    Hatano, Etsuro
    Ohkawa, Shinichi
    Fujii, Hirofumi
    Masumoto, Akihide
    Furuse, Junji
    Wada, Yoshiyuki
    Ishii, Hiroshi
    Obi, Shuntaro
    Kaneko, Shuichi
    Kawazoe, Seiji
    Yokosuka, Osamu
    Ikeda, Masafumi
    Ukai, Katsuaki
    Morita, Sojiro
    Tsuji, Akihito
    Kudo, Toshihiro
    Shimada, Mitsuo
    Osaki, Yukio
    Tateishi, Ryosuke
    Sugiyama, Gen
    Abada, Paolo Benjamin
    Yang, Ling
    Okusaka, Takuji
    Zhu, Andrew Xiuxuan
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (04) : 494 - 503
12345